Cambridge Cognition Holdings (COG) Fair Value & Analysis
Healthcare · GB · Market cap 17.2M GBX
Fair value as of: Jun 24, 2026
From 2 valuation models · updated 5 days ago
Share price −9.5% over the past month.
Price vs Fair Value (12 months)
12‑month range £0.2575 – £0.4480 · fair‑value band £0.2200 – £0.3600 · the £0.3450 price screens above the £0.2900 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Cambridge Cognition Holdings (COG) currently trades at £0.3450, while our model-based Fair Value estimate is £0.2900 — implying the stock looks roughly 15.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Cambridge Cognition Holdings generated revenue of £9.4M at a net margin of -17.8%. Revenue grew 7.3% year over year. It earns a return on equity of -52.7%. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Cambridge Cognition Holdings reported revenue of £9.4M in FY2025 versus £10.1M in FY2021, a compound −1.8%/yr. Reported net income was −£1.7M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $163.76 | $103.58 | -37% |
| Pro Medicus Limited PME | A$172.80 | A$32.25 | -81% |
| BrightSpring Health Services, Inc BTSG | $57.40 | $23.87 | -58% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $89.72 | $54.47 | -39% |
| M3, Inc MTHRY | $5.03 | $7.44 | +48% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Cambridge Cognition Holdings (COG) undervalued?
What is the fair value of COG?
What is the quality score of COG?
What is the revenue of Cambridge Cognition Holdings (COG)?
What is the net profit margin of COG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.